Welcome to Suspect PH

Suspect PH is an online resource for healthcare professionals to learn more information about pulmonary hypertension (PH), specifically pulmonary arterial hypertension (PAH), how to look for it, and what to do if you suspect it in one of your patients.

PAH is a rare, but serious, progressive condition with high rates of morbidity and mortality.1 When left untreated, prognosis is poor, with median survival as low as 6 months for patients with advanced disease.2

Early diagnosis of PAH is crucial, with intervention at this point likely to delay disease progression and improve patient outcomes.3 However, the reality in Australia is that the average delay from symptom onset to diagnosis of PAH is almost 4 years, including 5 GP and 3 specialist visits.4

How you can help

As a physician who may have patients with PAH, you play a vital role in ensuring patients get diagnosed and treated as quickly as possible. The simplest way to achieve these goals is by promptly referring your suspected PAH patients to a PAH expert centre. These centres have the expertise to definitively diagnose and treat PAH, providing optimal management of this complex disease.

Suspect PH aims to help you understand more about your role in diagnosing PAH, and makes it easy for you to suspect, detect and refer your patient to their nearest PAH expert centre: 

References
  1. McLaughlin VV, et al. J Am Coll Cardiol 2009; 53:1573–619.
  2. D’Alonzo GE, et al. Ann Intern Med 1991; 115:343–49.
  3. Humbert M, et al. Eur Respir Rev 2012; 21(126): 306–12.
  4. Strange G, et al. Pulm Circ 2013; 3:89–94.

Do you need guidance on referring to a PAH specialist?

Complete a short questionnaire to receive instant feedback.

This content is intended for Australian healthcare professionals. For more information on pulmonary hypertension, please contact your healthcare professional.
Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

World Health Organization functional class (WHO-FC) for patients with PH3,5

This system grades PH severity according to the patient’s functional status, by linking symptoms with activity limitations. WHO-FC remains a powerful predictor of outcomes in patients with PAH.

WHO - FC Description
I
Patients with PH in whom there is no limitation of usual physical activity; ordinary physical activity does not cause increased dyspnoea, fatigue, chest pain, or presyncope.
II
Patients with PH who have mild limitation of physical activity. There is no discomfort at rest, but normal physical activity causes increased dyspnoea, fatigue, chest pain, or presyncope.
III
Patients with PH who have a marked limitation of physical activity. There is no discomfort at rest, but less than ordinary activity causes increased dyspnoea, fatigue, chest pain, or presyncope.
IV
Patients with PH who are unable to perform any physical activity at rest and who may have signs of right ventricular failure. Dyspnoea and/or fatigue may be present at rest, and symptoms are increased by almost any physical activity.
Adapted from McGoon M, et al. 2004.5
Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

Icon/Leaving SiteCreated with Sketch.

Leaving website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the Company or via the Product Information.

This website is intended for Australian healthcare professionals only